Submissions for variant NM_007272.3(CTRC):c.640-12G>A

gnomAD frequency: 0.00194  dbSNP: rs183053579

Total submissions: 6

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories	RCV000507043	SCV000603264	likely pathogenic	Hereditary pancreatitis	2022-10-21	criteria provided, single submitter	clinical testing	The CTRC c.640-12G>A variant (rs183053579) is reported in the literature in multiple individuals affected with pancreatitis (Giefer 2017, LaRusch 2015, Masson 2015). Functional characterization of patient mRNA indicates that the variant leads to the inclusion of 10 nucleotides from intron 6, potentially introducing a frameshift in the translated protein (Masson 2015). This variant is reported in ClinVar (Variation ID: 439575), and is found in the African population with an allele frequency of 0.65% (162/24,920 alleles, including a single homozygote) in the Genome Aggregation Database. This is an intronic variant in a weakly conserved nucleotide, but computational analyses (Alamut v.2.11) predict that this variant may impact splicing by creating a novel cryptic acceptor splice site, consistent with the functional studies. Based on available information, the c.640-12G>A variant is considered to be likely pathogenic. References: Giefer MJ et al. Early-Onset Acute Recurrent and Chronic Pancreatitis Is Associated with PRSS1 or CTRC Gene Mutations. J Pediatr. 2017 Jul;186:95-100. PMID: 28502372. LaRusch J et al. The Common Chymotrypsinogen C (CTRC) Variant G60G (C.180T) Increases Risk of Chronic Pancreatitis But Not Recurrent Acute Pancreatitis in a North American Population. Clin Transl Gastroenterol. 2015 Jan 8;6:e68. PMID: 25569187. Masson E et al. Report of 2 CTRC Intronic Mutations Associated With Acute or Chronic Pancreatitis and Delineation of Their Pathogenic Molecular Mechanisms. Pancreas. 2015; 44(6):999-1001. PMID: 26166474.
Labcorp Genetics (formerly Invitae), Labcorp	RCV000507043	SCV002486560	benign	Hereditary pancreatitis	2025-01-15	criteria provided, single submitter	clinical testing
Mendelics	RCV002248742	SCV002519073	uncertain significance	not specified	2022-05-04	criteria provided, single submitter	clinical testing
Sema4, Sema4	RCV000507043	SCV002537668	uncertain significance	Hereditary pancreatitis	2021-04-23	criteria provided, single submitter	curation
Ambry Genetics	RCV000507043	SCV002658536	uncertain significance	Hereditary pancreatitis	2024-07-10	criteria provided, single submitter	clinical testing	The c.640-12G>A intronic variant results from a G to A substitution 12 nucleotides upstream from coding exon 7 in the CTRC gene. This variant was reported in individuals with acute recurrent or chronic pancreatitis (LaRusch J et al. Clin Transl Gastroenterol, 2015 Jan;6:e68; Masson E et al. Pancreas, 2015 Aug;44:999-1001; Giefer MJ et al. J Pediatr, 2017 Jul;186:95-100). RNA studies have demonstrated that this alteration results in partial intron retention; however, the clinical impact of this abnormal splicing is unknown (Masson E et al. Pancreas, 2015 Aug;44:999-1001). This nucleotide position is poorly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will result in the creation or strengthening of a novel splice acceptor site. Based on the available evidence, the clinical significance of this variant remains unclear.
PreventionGenetics, part of Exact Sciences	RCV004730965	SCV005339165	uncertain significance	CTRC-related disorder	2024-03-25	no assertion criteria provided	clinical testing	The CTRC c.640-12G>A variant is predicted to interfere with splicing. This variant has been reported in association with chronic pancreatitis (Masson et al. 2015. PubMed ID: 26166474; Giefer et al. 2017. PubMed ID: 28502372). Sequencing of RT-PCR products derived from patients harboring the c.640-12G>A variant revealed an aberrant mRNA transcript incorporating the last 10bp of intron 6 into exon 7, which is predicted to result in a frameshift and protein extension (Masson et al. 2015. PubMed ID: 26166474). This variant occurs relatively frequently in the gnomAD general population database, with a subpopulation allele frequency as high as 0.63% in Africans, including one homozygote, which is likely too common to be a highly penetrant cause of disease. While it is possible that this variant may contribute to chronic pancreatitis phenotypes with incomplete penetrance, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.